c ebpβ-lip drug Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | Journal of Experimental & Clinical Cancer Research Frontiers | C/EBPβ as a
Frontiers C EBP as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications Transcriptional Control of COX 2 via C EBP Arteriosclerosis, Thrombosis, and Vascular Biology A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports C EBP: A transcription factor associated with the irreversible progression of Alzheimer's disease Yao 2024 CNS Neuroscience & Therapeutics Wiley Online Library
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



